New drugs for Parkinson's disease

August 1997

Get ready for a slew of new drugs for Parkinson's disease.

The FDA just approved Mirapex (pramipexole)...next will be Requip (ropinirole) and Tasmar (tolcapone).

These are the first new drugs for Parkinson's since selegiline was approved almost ten years ago.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Changes in the use of diet pills for weight loss.
Diabetes Significant drug interactions with the new diabetes drug Rezulin (troglitazone)
Diabetes Major changes in their recommendations for screening and diagnosing diabetes
Gastroenterology Prevacid (lansoprazole) for duodenal ulcers caused by H. pylori
Cardiology Posicor (mibefradil), a new calcium blocker for hypertension and angina
Cardiology A common infection might increase the risk of heart attacks
Psoriasis Tazorac (TAZ-or-ac, tazarotene), a new topical retinoid gel
Psoriasis Several new OTCs for psoriasis
Psoriasis Skin-Cap and DermaZinc contain pyrithione zinc
Women's Health Crinone, a vaginal gel containing micronized progesterone
Ophthalmology Cordarone (amiodarone) might cause vision loss
Ophthalmology Two new artificial tears products
Renal & Urology Edex, a penile injection for impotence
Renal & Urology Calcium supplements INCREASE the risk of kidney stones
Accolate (zafirlukast) MIGHT lead to liver dysfunction
New concern about Accolate and Churg-Strauss Syndrome
Tavist Sinus that DOESN'T contain the antihistamine clemastine
New antibiotic guidelines have just been released for dental patients with total joint replacements
Parkinson Disease New drugs for Parkinson's disease
Practice The Confide HIV home test is going off the market